Streetbeat News

Analyst Ratings

VCTR

BMO Capital analyst Etienne Ricard has maintained an 'Outperform' rating on Victory Capital Holdings (NASDAQ:VCTR) but lowered the price target from $47 to $45.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:56 pm

BNTX

MRNA

PFE

The Nobel Assembly has awarded the Nobel Prize in medicine to Katalin Kariko and Drew Weissman for their work in the development of mRNA vaccines against Covid-19. Their research paved the way for companies like Moderna Inc. and the Pfizer Inc. – BioNTech SE partnership to rapidly develop mRNA-based vaccines. Despite this, shares of Moderna and Pfizer have experienced a 43% and 35% decline year-to-date respectively.

Portfolio Pulse from Piero Cingari

October 02, 2023 | 12:55 pm

HMY

Harmony Gold's shares are trading lower due to a decrease in gold prices and JP Morgan analysts lowering their price target on the stock.

Portfolio Pulse from Luke J Jacobi

October 02, 2023 | 12:53 pm

SYRS

Syros Pharmaceuticals (NASDAQ:SYRS) announced a strategic realignment and CEO transition. Conley Chee, CCO and CBO, will succeed Nancy Simonian as CEO, effective December 1, 2023. The company plans a workforce reduction of approximately 35% to focus on late-stage development of tamibarotene in MDS and AML. Syros will stop further investment in SY-2101 due to capital constraints. The company is preparing to report initial data from SELECT-AML-1 later this year and pivotal data from SELECT-MDS-1 next year.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:49 pm

ETSY

Wedbush analyst Seth Basham has initiated coverage on Etsy (NASDAQ:ETSY) with a Neutral rating and a price target of $70.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:41 pm

ZWS

Oppenheimer analyst Bryan Blair has reiterated an Outperform rating on Zurn Elkay Water (NYSE:ZWS) and maintained a $33 price target.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:37 pm

ANF

ARDX

AWK

CAT

FUBO

XOM

Jim Cramer, on CNBC’s 'Mad Money Lightning Round,' recommended buying Caterpillar Inc. (CAT), Abercrombie & Fitch Co. (ANF), Exxon Mobil Corporation (XOM), and American Water Works Company, Inc. (AWK). He referred to Ardelyx, Inc. (ARDX) as a 'speculative stock' and advised against investing in fuboTV Inc. (FUBO).

Portfolio Pulse from Priya Nigam

October 02, 2023 | 12:34 pm

MIRM

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) has announced positive data from the Phase 3 RESTORE study evaluating Chenodal tablets in patients with cerebrotendinous xanthomatosis (CTX). The study met its primary endpoint with a significant reduction in bile alcohols. The company plans to submit these data to the FDA and file a new drug application in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:33 pm

ICVX

Oppenheimer analyst Hartaj Singh has reiterated an 'Outperform' rating on Icosavax (NASDAQ:ICVX) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:31 pm

PODD

Jefferies has upgraded Insulet's stock from Hold to Buy, leading to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:30 pm